Phase I trial of weekly gemcitabine with radiotherapy for unresectable locally advanced biliary tract cancer.
Phase 1
- Conditions
- Biliary tract cancer
- Registration Number
- JPRN-UMIN000022562
- Lead Sponsor
- Sapporo medical university, department of medical oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
No previous history of treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse events within two weeks after treatment.
- Secondary Outcome Measures
Name Time Method Maximum tolerated dose, toxicity